<VariationArchive VariationID="1068464" VariationName="NM_182931.3(KMT2E):c.4829dup (p.Leu1610fs)" VariationType="Duplication" Accession="VCV001068464" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1060940" VariationID="1068464">
      <GeneList>
        <Gene Symbol="KMT2E" FullName="lysine methyltransferase 2E (inactive)" GeneID="55904" HGNC_ID="HGNC:18541" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="105014205" stop="105115019" display_start="105014205" display_stop="105115019" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="104654636" stop="104754531" display_start="104654636" display_stop="104754531" Strand="+" />
          </Location>
          <OMIM>608444</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2E">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2E">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_182931.3(KMT2E):c.4829dup (p.Leu1610fs)</Name>
      <CanonicalSPDI>NC_000007.14:105112579:TTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="105112579" stop="105112580" display_start="105112579" display_stop="105112580" variantLength="1" positionVCF="105112579" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="104753026" stop="104753027" display_start="104753026" display_stop="104753027" variantLength="1" positionVCF="104753026" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>L1610fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.104753032dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.104753032dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.105112585dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.105112585dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033949.1" sequenceAccession="NG_033949" sequenceVersion="1" change="g.103396dup">
            <Expression>NG_033949.1:g.103396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018682.4" sequenceAccession="NM_018682" sequenceVersion="4" change="c.4829dup">
            <Expression>NM_018682.4:c.4829dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061152.3" sequenceAccession="NP_061152" sequenceVersion="3" change="p.Leu1610fs">
            <Expression>NP_061152.3:p.Leu1610fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_182931.3" sequenceAccession="NM_182931" sequenceVersion="3" change="c.4829dup" MANESelect="true">
            <Expression>NM_182931.3:c.4829dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_891847.1" sequenceAccession="NP_891847" sequenceVersion="1" change="p.Leu1610fs">
            <Expression>NP_891847.1:p.Leu1610fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1404" sequenceAccession="LRG_1404">
            <Expression>LRG_1404:g.103396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1404t1" sequenceAccession="LRG_1404t1">
            <Expression>LRG_1404t1:c.4829dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1404p1" sequenceAccession="LRG_1404p1" change="p.Leu1610fs">
            <Expression>LRG_1404p1:p.Leu1610fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_182931.2" sequenceAccession="NM_182931" sequenceVersion="2" change="c.4829dupT">
            <Expression>NM_182931.2:c.4829dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608444.0008" DB="OMIM" />
        <XRef Type="rs" ID="1243172283" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_182931.3(KMT2E):c.4829dup (p.Leu1610fs) AND not provided" Accession="RCV001380028" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_182931.3(KMT2E):c.4829dup (p.Leu1610fs) AND O'Donnell-Luria-Rodan syndrome" Accession="RCV001420174" Version="2">
        <ClassifiedConditionList TraitSetID="48183">
          <ClassifiedCondition DB="MedGen" ID="C5193138">O'Donnell-Luria-Rodan syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-28" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_182931.3(KMT2E):c.4829dup (p.Leu1610fs) AND Inborn genetic diseases" Accession="RCV004037640" Version="1">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-14" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31079897</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34321323</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48183" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42272" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">O'Donnell-Luria-Rodan syndrome</ElementValue>
                <XRef ID="MONDO:0032793" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ODLURO</ElementValue>
                <XRef Type="MIM" ID="618512" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">KMT2E-Related Neurodevelopmental Disorder</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">38648332</ID>
                <ID Source="BookShelf">NBK602945</ID>
              </Citation>
              <XRef ID="C5193138" DB="MedGen" />
              <XRef ID="MONDO:0032793" DB="MONDO" />
              <XRef Type="MIM" ID="618512" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3193634" SubmissionDate="2021-05-11" DateLastUpdated="2021-05-20" DateCreated="2021-05-20">
        <ClinVarSubmissionID localKey="KMT2E:c.4829dup|OMIM:618512" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001622596" DateUpdated="2021-05-20" DateCreated="2021-05-20" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, Cologne University" OrgID="243629" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2E" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_182931.2:c.4829dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618512" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9612516</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3103554" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="3541764|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001577955" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31079897</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change results in a frameshift in the KMT2E gene (p.Leu1610Phefs*259). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 249 amino acid(s) of the KMT2E protein and extend the protein by 9 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individual(s) with clinical features of KMT2E-related neurodevelopmental disorder (PMID: 31079897). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1068464). This variant results in an extension of the KMT2E protein. Other variant(s) that result in a similarly extended protein product (p.Pro1686Serfs*183) have been determined to be pathogenic (Invitae). This suggests that these extensions are likely to be disease-causing.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2E" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.104753026_104753027insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8994610" SubmissionDate="2024-04-08" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="608444.0008_O'DONNELL-LURIA-RODAN SYNDROME" title="KMT2E, 1-BP DUP, 4829T_O'DONNELL-LURIA-RODAN SYNDROME" />
        <ClinVarAccession Accession="SCV004811987" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient (patient 10) with O'Donnell-Luria-Rodan syndrome (ODLURO; 618412), O'Donnell-Luria et al. (2019) identified a de novo heterozygous duplication at nucleotide 4829 (c.4829dupT, NM_182931.2) in the KMT2E gene, predicted to result in a frameshift and protein extension (Leu1610PhefsTer259). Velmans et al. (2022) reported another boy with ODLURO who had the same de novo heterozygous mutation. The mutation is predicted to escape nonsense-mediated decay.</Attribute>
              <Citation>
                <ID Source="PubMed">31079897</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">34321323</ID>
              </Citation>
              <XRef DB="OMIM" ID="618412" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2E" />
          </GeneList>
          <Name>KMT2E, 1-BP DUP, 4829T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 4829T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608444.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">O'DONNELL-LURIA-RODAN SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9104091" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="a0228610|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004896649" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31079897</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34321323</ID>
          </Citation>
          <Comment>The c.4829dupT (p.L1610Ffs*259) alteration, located in exon 27 (coding exon 25) of the KMT2E gene, consists of a duplication of T at position 4829, causing a translational frameshift with a predicted alternate stop codon after 259 amino acids. This alteration occurs at the 3' terminus of the KMT2E gene, is not expected to trigger nonsense-mediated mRNA decay and results in the elongation of the protein by 11 amino acids. This frameshift impacts the last 13% of the native protein. Frameshifts are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been determined to be the result of a de novo mutation in two individuals with features consistent with O'Donnell-Luria-Rodan syndrome (O'Donnell-Luria, 2019; Velmans, 2022). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2E" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_182931.2:c.4829dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3193634" TraitType="Disease" MappingType="XRef" MappingValue="618512" MappingRef="OMIM">
        <MedGen CUI="C5193138" Name="O'Donnell-Luria-Rodan syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9104091" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994610" TraitType="Disease" MappingType="Name" MappingValue="O'DONNELL-LURIA-RODAN SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C5193138" Name="O'Donnell-Luria-Rodan syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3103554" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

